Abstract
WYETH PHARMACEUTIcals and the Health Ministry of Scotland have formed the Translational Medicine Research Collaboration. With the support of Scotland's National Health Service (NHS) and economic development agency, Scottish Enterprise, TMRC will combine efforts at Wyeth with those of four Scottish medical universities. Scottish Enterprise says it will invest $30 million in the collaboration; Wyeth will contribute $57 million in the first five years and has an option to continue funding over another five years. Translational medicine seeks to integrate drug research and development and patient response to create new, more personalized therapies and diagnostics. It is a part of NIH's Roadmap for Medical Research, and many major drug firms, including Novartis, Glaxo-SmithKline, and Wyeth, have established internal translational research groups to increase the information flow between their R&D and clinical programs as a means to improve productivity in both areas. In addition, Astra-Zeneca is collaborating w...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
